NetworkNewsBreaks

WednesdayApr 13, 2022 11:22 am

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Marks Historic Week with Shipments of Uranium, Vanadium, REE

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, hit a critical mineral “trifecta” this month, making commercial shipments of uranium, vanadium and advanced rare earth materials — all in a single week. According to the announcement, the company shipped natural uranium concentrates (“U308”) to the Metropolis Works uranium conversion facility in Metropolis, Illinois;  vanadium pentoxide (“V205”) to the Bear Metallurgical Company in Butler, Pennsylvania; and high-purity mixed rare earth element (“REE”) carbonate to the Neo Performance Materials facility in Estonia. “I believe the week of April 4, 2022, will go down as one of the most important weeks in…

Continue Reading

TuesdayApr 12, 2022 3:06 pm

NetworkNewsBreaks – Organa Kannalytics Announces IBN’s HempWire as Official NewsWire of Southeastern Hemp & Medical Cannabis Convention

Organa Kannalytics has chosen InvestorBrandNetwork’s HempWire brand as an official media sponsor and official NewsWire of the Southeastern Hemp & Medical Cannabis Convention (“SHMC”). The three-day convention is scheduled for May 12–14, 2022, in Atlanta; the event will also be livestreamed. Organa Kannalytics is committed to bringing legitimacy to the hemp and medical cannabis industry by delivering science and education through its premier events. The SHMC expo features breakout sessions covering medical use and practices, business opportunities, the latest in scientific advancements, and local, state and national legislation affecting the cannabis and hemp industries; the event also offers invaluable networking…

Continue Reading

TuesdayApr 12, 2022 2:41 pm

NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New Director, CEO

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced that its board of directors has nominated Dr. David R. Richards, PhD, FIoD, FRSA, CPsych, as a new director and the company’s chief executive officer. Richards comes to the new positions with impressive experience, including serving in leadership roles at Nortel Networks' GM Global Data; GM Global Supercarriers; GM UK Switching; and Global ThinkQuest Champion at Oracle's Education Foundation. He has served as CEO of Ellis Jones Solicitors, executive director of…

Continue Reading

TuesdayApr 12, 2022 1:59 pm

NetworkNewsBreaks – GSMI’s Upcoming Event to Focus on Leveraging Social Media to Engage Communities

Global Strategic Management Institute (“GSMI”), a cutting-edge conference production company focused on promoting disruptive innovation, today announced that it will host the upcoming Social Media Strategies Summit for Public Agencies & Government in a virtual format on May 12-13, 2022. The event is designed to assist those working in government departments to leverage social media to humanize their agencies and engage the communities they serve. The summit will offer public sector professionals a host of innovative strategies and approaches to handle issues and situations. The event will feature a series of live 45-minute presentations, panel discussions and case studies. Engaging…

Continue Reading

TuesdayApr 12, 2022 1:13 pm

NetworkNewsBreaks – CannabisNewsWire to Shine the Spotlight on the 2022 O’Cannabiz Conference and Expo

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 50+ brands of IBN (“InvestorBrandNetwork”), today announced that it will again collaborate with the organizers of the O’Cannabiz International Conference & Expo. CNW is a platinum sponsor and will serve as the official newswire of the conference slated to take place June 1-3, 2022, at Toronto’s International Centre, Exhibit Hall 5. Working closely with O’Cannabiz, CNW will leverage IBN’s extensive array of corporate communications solutions to boost recognition for conference participants seeking to reach additional investors, journalists, businesses and consumers. CannabisNewsWire will provide amplified article syndication…

Continue Reading

TuesdayApr 12, 2022 1:03 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Update on Human Nicotine Study NIC-H22-1

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced details of human nicotine study NIC-H22-1, which is expected to begin dosing this summer. According to the announcement, NIC-H22-1 is a minimum 36-person human pharmacokinetic (“pk”) randomized, double blinded, cross-over study to compare Lexaria's DehydraTECH-nicotine pouch performance to that of existing leading brands currently sold in the U.S. such as ON! and Zyn. Lexaria hopes to evidence that processing purified nicotine with DehydraTECH leads to better oral-tissue absorption and reduced negative experiences compared to brands currently on the market. The study’s primary objective is data collection…

Continue Reading

TuesdayApr 12, 2022 12:54 pm

NetworkNewsBreaks – Denali Capital Acquisition Corp. (NASDAQ: DECAU) Announces Pricing of $75M IPO

Denali (NASDAQ: DECAU) recently announced the pricing of its initial public offering (“IPO”) of 7,500,000 units, each at a price of $10.00. Approved for listing on the NASDAQ Global Market, the units commenced trading under the symbol DECAU beginning on April 7, 2022. Each unit issued in the IPO consists of one Class A ordinary share and one redeemable warrant, with each whole warrant exercisable to purchase one whole Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, Class A ordinary shares and warrants are expected to be listed…

Continue Reading

TuesdayApr 12, 2022 12:47 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Leading Cannabis Event

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced that CEO Luis Merchan will be presenting at the upcoming Benzinga Cannabis Capital Conference. The event is scheduled for April 20–21, 2022, in Miami, Florida. Merchan’s presentation is slated to begin at 3:20 p.m. ET on April 20. In addition to Merchan’s presentation, members of Flora's management team will be scheduling one-on-one investor meetings throughout the day. The Benzinga Cannabis Capital Conference gathers together more than 1,000 of the top movers and shakers in the cannabis industry and offers an invaluable opportunity for…

Continue Reading

TuesdayApr 12, 2022 12:40 pm

NetworkNewsBreaks – SPYR Inc.’s (SPYR) Applied Magix Exploring AI Applications for Inclusion into IoT Products

SPYR (OTCQB: SPYR) (dba SPYR Technologies) is a technology company whose subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar smart home and connected car markets. The company today announced that Applied Magix is exploring AI applications for inclusion into its products. Also known as artificial intelligence, AI is the branch of computer science that aims to answer the question, “Can machines think?” – and the endeavor to replicate or simulate human intelligence in machines. “As part of our Secret Lab initiatives, AI frequently comes to the forefront of product development and how to…

Continue Reading

TuesdayApr 12, 2022 12:29 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate in Upcoming Virtual Investor Event

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be part of a moderated fireside chat during the Virtual Investor Glioblastoma Multiforme (“GBM”) Spotlight event on April 14, 2022. The chat is scheduled for 11:30 a.m. ET and will include CNS Pharmaceuticals management team members, including CEO John Climaco, along with opinion leader Samuel A. Goldlust, MD. The focus of the chat will be GBM and the work that CNS Pharmaceuticals is doing to advance Berubicin, its novel anthracycline and the first anthracycline to…

Continue Reading